Subject: MJTV Making Progress PZOO Updates on Subsidiary

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
MJTV Making Progress PZOO Updates on Subsidiary
Hot Stock to WatchHot Stock to Watch

Pazoo Inc. (Pink Sheets: PZOO)

End of Day:

Price: 0.0003

Change (%): + 0.00 (0.00)

Volume: 18,674,464
PZOO Chart

Denver Colorado Cannabis Testing Lab Now Meets SOP State Standards And Is In Position To Begin Accepting Industrial Hemp Samples

WHIPPANY, N.J., Feb. 17, 2016 /PRNewswire/ - Pazoo, Inc. (OTC Pinks: PZOO) (German WKN#: A1J3DK) is pleased to announce that Front Range Analytical which is in the final approval stages to be managed by Harris Lee Colorado now can accept samples of Industrial Hemp as part of its Standard Operating Procedures. Industrial Hemp sample testing will commence as soon as the tracking system for State of Colorado (Metrc) has finished integrating industrial hemp into the system.

By accepting industrial hemp samples, Front Range and Harris Lee Colorado will be able to dramatically diversify the clientele and greatly increase sample intake resulting in an exponential increase in revenue generation. Front Range and Harris Lee Colorado are positioning to be the premier testing lab in the state of Colorado.

Continue Reading

Company: Michael James Enterprises Inc. (Pink Sheets: MJTV)

End of Day:

Price: 0.175

Change (%): + 0.00 (0.00)

Volume: 0
MJTV Chart

Michael James Enterprises Skin Care Formulator Delivers First Draft of Acne Kit To Ivy League Institution And Receives Formulation Approval

Facebook Page Goes Live

SHORT HILLS, N.J., Feb. 17, 2016 /PRNewswire/ - Michael James Enterprises, Inc. (OTC: MJTV), delivered the first set of samples of its 4 product acne kit to the creator of the patented technology at the renowned Ivy League institution and received confirmation that the formulations are properly combined. MJTV also went live with its Facebook page which can be viewed by going to the following link

Konstantinos M. Lahanas, Ph.D, of The Lahanas Group reported that the next step in the formulation process is to add in aromas and resubmit for final approval prior to moving onto the next steps.

Continue Reading

Top PerformerYesterday's Top Performer

Company: PositiveID Corporation (OTCQB: PSID)

End of Day:

Price: 0.0168

Change (%): + 0.0012 (7.69)

Volume: 2,360,600
PSID Chart

PositiveID Corporation to Present at the SeeThruEquity Innovations Investor Conference on February 22, 2016

DELRAY BEACH, Fla., Feb. 16, 2016 (GLOBE NEWSWIRE) - PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today that its Chairman and CEO, William J. Caragol, will present at the SeeThruEquity Second Annual Innovations Investor Conference in Miami, FL, on Monday, February 22, 2016, at the Ritz Carlton on South Beach.

Mr. Caragol will provide an update on PositiveID’s Firefly Dx real-time pathogen detection system, as well as an overview of the Company’s recent acquisitions of Thermomedics, which markets the FDA-cleared, non-contact Caregiver® thermometer, and E-N-G Mobile Systems, Inc. (“ENG”), a leader in mobile labs, homeland security and communications vehicles.

Continue Reading

Other Small Cap News

Company: Global Future City Holding Inc. (OTCQB: FTCY)

Global Future City Holding Inc. Announces 3.5 Million Dollars Generated in GX-Life Global Membership Financing

IRVINE, Calif., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Global Future City Holding Inc. (OTCQB:FTCY) (the “Company”) is pleased to announce that its wholly-owned subsidiary, GX-Life Global, Inc., has sold 3.5 million dollars of premium membership interests in its marketing program. GX-Life’s marketing program supports a line of consumer based products, including beauty, energy, nutrition and tea products, and may be viewed at its website Subject to certain conditions, members can use their status reward points to buy products or eventually convert to GX Coin (upon completion of its technology development).

GX-Life Global is also finalizing a Technology License Agreement with GX-Coin, Inc. under which GX-Life Global has licensed one of the first digitally-based blockchain supported currencies, into its membership compensation plan, to further support its marketing activities by providing additional financial incentives for its members. GX-Coin is affiliated through common management, but is a separate entity focusing upon technology development to support digital currency creation, deployment and trading.

Continue Reading

Company: Protea Biosciences Group, Inc. (OTCQB: PRGB)

Protea Announces Collaborative Partnership With Protein Metrics

Protea to Use Novel Proteomics Software to Support Biopharma Research

MORGANTOWN, W. Va., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Protea Biosciences Group, Inc. (OTCQB:PRGB) (“Protea”) announced today it is collaborating with Protein Metrics Inc., a premier provider of software solutions for the comprehensive characterization of proteins, to advance new analytical capabilities for use in the development of protein biotherapeutics.

“We are positioning Protea to be a leader in the next generation of bioanalytics, focused on the needs of the biotherapeutics industry,” stated Greg Kilby, Ph.D., Protea’s Vice President and Chief Operating Officer. He added, “Our Protein Metrics collaboration will provide Protea access to advanced software for comprehensive protein characterization, PTM analysis, and sequence variant analysis.

Continue Reading

Company: Rocky Mountain High Brands, Inc. (Pink Sheets: RMHB)

Rocky Mountain High Brands, Inc. (RMHB) Names Winton Morrison as New Board Member

DALLAS, Feb. 17, 2016 (GLOBE NEWSWIRE) -- Rocky Mountain High Brands, Inc. (OTC PINK:RMHB) announced today that New York State Business Executive/Owner, Winton "Win" Morrison, has joined the Rocky Mountain High Board of Directors.

WIN MORRISON REALTY (WMR) is one of the largest sellers of Commercial and Residential properties in the Hudson Valley. WMR has been at the forefront of helping bring to life a myriad of economic development initiatives within the region, from retail to restaurant business openings along the Kingston Rondout waterfront to shopping malls, performing arts centers, apartment complexes, and medium to large industrial sites.

Continue Reading

Company: RegenBioPharma, Inc. (OTCBB: RGBP)

Regen BioPharma, Inc.'s Immune Checkpoint Inhibitor Found to Stimulate Key Immune System Proteins Interleukin-17 and Interleukin-18

Results from Ongoing Studies Suggest Major Role of Regen's NR2F6 Target in Controlling Key Immune Functions

SAN DIEGO, February 17, 2016 /PRNewswire/ -- RegenBioPharma, Inc ., (OTCBB: RGBP) and (PINK: RGBP) announced today the filing of two patent applications covering new immunological pathways activated by gene silencing of the Company's checkpoint inhibitor target NR2F6. The results, which are part of a collaborative effort with Dr. Santosh Kesari, demonstrate that suppression of NR2F6 in T cells results in increased expression of key immune stimulatory proteins interleukin-17 (IL-17) and interleukin-18 (IL-18). Dr. Santosh Kesari serves as the Professor of Neurosciences and Chair of the Department of Neuro-oncology and Neuro-Therapeutics at the John Wayne Cancer Institute (Providence Saint John's Health Center).

Continue Reading

Market News

By Ben Hirschler and Amrutha Penumudi: Reuters

Zika vaccine shows promise in mice, lifting maker Inovio

Hopes of developing a vaccine against Zika took a small step forward on Wednesday as Inovio Pharmaceuticals Inc (INO.O) said its experimental shot had induced a robust and durable response in mice.

Shares in the U.S. biotech firm, which expects to test its product in humans before the end of the year, jumped 7 percent in premarket trading on the prospect of it developing a vaccine against the mosquito-borne disease.

At least 15 companies and academic groups are currently racing to develop Zika vaccines, according to the World Health Organization (WHO), spurred on by growing public concern over the virus sweeping across the Americas.

Continue Reading

By Stuart Smith:, Inc.

PositiveID Corp. and GenArraytion, Inc. Join Forces as the Threat of Zika Continues to Rise

Feb. 2, 2016 PositiveID Corp. (OTCQB:PSID) has partnered with GenArraytion, Inc. who recently announced the development of the first commercially available polymerase chain reaction (PCR)-based molecular test to identify the Zika virus, a fever-causing disease transmitted by the Aedes aegypti mosquito. The Zika virus test works with an existing GenArraytion MultiFLEX™ Bioassay panel that targets viruses that cause dengue fever, yellow fever and Chikungunya, which are also carried by this mosquito and are known to cause febrile disease in humans. The Aedes Aegypti MultiFLEX™Bioassay test is designed to work on bead-based endpoint instruments and real-time PCR platforms, such as Positive ID’s, Firefly DX. The test targets four genetic regions of the Zika virus, making detection possible even if the virus mutates in the future. MultiFLEX™ molecular assays help health officials identify infectious diseases in panels with up to 20 genetic markers, for fever-causing and vector-borne disease organisms of concern.

PositiveID’s Firefly Dx is a hand-held unit designed to analyze biological samples and deliver molecular diagnostic results in less than 30 minutes. The portable nature of the Firefly Dx enables health care officials working in the field to accurately test and diagnose individuals on-the-spot. The rapid response of the Firefly Dx could allow officials to quickly assess a population’s exposure and enact measures to contain and prevent further spread of the infectious disease. To date, Firefly has demonstrated the ability to detect and identify many pathogens and diseases including, Ebola, measles, seasonal and avian flu, E. coli, and methicillin-resistant staphylococcus aureus (“MRSA”). With the use of GenArrayation Inc.’s assays in the future, Firefly Dx may also detect Zika, dengue fever, yellow fever, and Chikungunya.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks